Eldepryl (Selegiline) helps to increase the level of dopamine in the brain by reducing its oxidation. Eldepryl is used for treatment of Parkinson's disease including symptomatic parkinsonism in patients. An active agent, selegilin, inhibits the metabolism of dopamine, increases its concentration in the brain and prevents deficiency of this substance. Selegilin is the only known agent against Parkinson’s disease that reduces a drop in dopamine .
Generic Eldepryl is also sold as: Selegiline, Zelapar.
*Eldepryl® is a product of Somerset Pharmaceuticals Inc.